Kindler HL, Hammel P, Reni M, Van Cutsem E, et al. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. J Clin Oncol 2022;40:3929-3939.
PMID: 35834777